Sensitization of acute lymphoblastic leukemia cells for LCL161-induced cell death by targeting redox homeostasis

Biochemical Pharmacology
Christina HaßSimone Fulda

Abstract

Disturbed redox homeostasis with both elevated reactive oxygen species (ROS) levels and antioxidant defense mechanisms has been reported in acute lymphoblastic leukemia (ALL). We therefore hypothesized that inhibition of pathways responsible for ROS detoxification renders ALL cells more susceptible for cell death. Here, we report that pharmacological inhibitors of key pathways for the elimination of ROS, i.e. Erastin, buthionine sulfoximine (BSO) and Auranofin, sensitize ALL cells for cell death upon treatment with the Smac mimetic LCL161 that antagonizes Inhibitor of Apoptosis (IAP) proteins. Erastin, BSO or Auranofin significantly increase LCL161-induced cell death and also act in concert with LCL161 to profoundly suppress long-term clonogenic survival in several ALL cell lines. Erastin or BSO cooperates with LCL161 to stimulate ROS production and lipid peroxidation prior to cell death. ROS production and lipid peroxidation are required for this cotreatment-induced cell death, since ROS scavengers or pharmacological inhibition of lipid peroxidation provides significant protection against cell death. These results emphasize that inhibition of antioxidant defense mechanisms can serve as a potent approach to prime ALL cells for ...Continue Reading

References

Apr 1, 1984·The Biochemical Journal·B Halliwell, J M Gutteridge
Apr 9, 2004·The New England Journal of Medicine·Ching-Hon PuiJames R Downing
Nov 22, 2005·Journal of Biochemical and Biophysical Methods·Ana GomesJosé L F C Lima
Nov 13, 2008·International Journal of Cancer. Journal International Du Cancer·Simone Fulda
Dec 23, 2008·Seminars in Hematology·Martin Stanulla, Martin Schrappe
Mar 21, 2009·British Journal of Haematology·Simone Fulda
May 30, 2009·Nature Reviews. Drug Discovery·Dunyaporn TrachoothamPeng Huang
May 29, 2012·Cell·Scott J DixonBrent R Stockwell
Aug 21, 2012·Antioxidants & Redox Signaling·Mary E IrwinJoya Chandra
Nov 26, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Simone Fulda
Nov 30, 2013·Nature Reviews. Drug Discovery·Chiara GorriniTak W Mak
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey R InfanteRoger B Cohen

❮ Previous
Next ❯

Citations

Apr 14, 2017·Current Opinion in Hematology·Agnieszka Graczyk-JarzynkaMalgorzata Firczuk
Feb 29, 2020·Antioxidants·Emiliano PanieriLuciano Saso
May 23, 2020·Apoptosis : an International Journal on Programmed Cell Death·Mark A MilesChristine J Hawkins
Jun 26, 2018·Journal of Medicinal Chemistry·Carlo BaggioMaurizio Pellecchia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis